EP3497131
COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4.
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.8.2017EP published:
9.3.2022EP application number:
17755592.7
EPO information:
European Patent Register
Max expiry date:
6.8.2037
Title in English:
COMBINATION OF T-CELL CHECKPOINT INHIBITORS WITH INHIBITORS OF E-SELECTIN OR CXCR4, OR WITH HETEROBIFUNCTIONAL INHIBITORS OF BOTH E-SELECTIN AND CXCR4.Language of the patent:
English
Timeline
Today
7.8.2017EP application
9.3.2022EP Publication
Owner
Name:
GlycoMimetics, Inc.Address:
9708 Medical Center Drive, Rockville, MD 20850, US
Inventor
Name:
MAGNANI, John L.Address:
Rockville Maryland 20850, US
Name:
FOGLER, William E.Address:
Rockville Maryland 20850, US
Priority
Number:
201662372116 PDate:
8.8.2016Country:
US
Number:
201662417045 PDate:
3.11.2016Country:
US
Number:
201662418722 PDate:
7.11.2016Country:
US
Classification
Categories:
C07K 16/28, A61K 31/7034, A61K 39/00